Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia

Molecular Medicine

Volumn 3, Issue 11, 1997, Pages 765-781

  Botchkina, Galina I ^a   Meistrell III, Malcolm E ^a   Botchkina, Inna L ^a   Tracey, Kevin J ^a,b  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0031470830     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401714     Document Type: Article

References (65)

1. Buttini M, Appel K, Sauter A, Gebicke-Haerter P-J, Boddeke H. (1996) Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat. Neuroscience 71: 1-16.
2. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. (1994) Tumor necrosis factor-α expression in ischemic neurons. Stroke 25: 1481-1488.
3. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesions. J. Neuroimmunol. 42: 177-186.
4. Woodroofe MN, Sarna GS, Wadhwa M, et al. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33: 227-236.
5. Tchelingerian J-L, Quinonero J, Booss J, Jacque C. (1993) Localization of TNF-α and IL-1 immunoreactivities in striatal neurons after surgical injury to hippocampus. Neuron. 10: 213-224.
6. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. (1996) Experimental brain injury induces differential expression of tumor necrosis factor-mRNA in the CNS. Mol. Brain Res. 36: 287-291.
7. Szaflarski J, Burtrum D, Silverstein FS. (1995) Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 26: 1093-1100.
8. Tracey KJ, Vlassara H, Cerami A. (1989) Cachectin/tumour necrosis factor. Lancet I: 1122-1126.
9. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. (1997) Tumor necrosis factor-α. A mediator of focal ischemic brain injury. Stroke 28: 1233-1244.
10. Meistrell III ME, Botchkina GI, Wang H, DeSanto E, Cockroft KM, Bloom O, Vishnubhakat JM, Ghezzi P, Tracey KJ. (1997) TNF is a brain-damaging cytokine in cerebral ischemia. Shock In press.
11. Dawson DA, Martin D, Hallenbeck JM. (1996) Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218: 41-44.
12. Navashiro H, Martin D, Hallenbeck JM. (1997) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 17: 229-232.
13. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsbert FW, Mattson MP. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2: 788-794.
14. Aggarwal BB. (1992) Comparative analysis of the structure and function of TNF-α and TNF-β. Immunol. Ser. 56: 61-78.
15. Turetskaya RL, Fashena SJ, Paul NL, Ruddle NH. (1992) Genomic structure, induction, and production of TNF-α. Immunol. Ser. 56: 35-60.
16. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. (1987) Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17: 1271-1278.
17. Sawada M, Kondo N, Suzumura A, Marunouchi T. (1989) Production of TNF-α by microglia and astrocytes in culture. Brain Res. 491: 394-397.
18. Lieberman AP, Pitha PM, Shin HS, Shin ML. (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. U.S.A. 86: 6348-6352.
19. Chung IY, Benveniste EN. (1990) Tumor necrosis factor alpha production by astrocytes. Induction by lipopolysaccharide, interferon gamma and interleukin 1 beta. J. Immunol. 144: 2999-3007.
20. Wesselingh SL, Gough NM, Finlay-Jones JJ, McDonald PJ. (1990) Detection of cytokine mRNA in astrocyte culture using the polymerase chain reaction. Lymphokine Res. 9: 177-185.
21. Tarlow MJ, Jenkins R, Comist SD, Osborne MP, Stephens S, Stanley P, Crokers J. (1993) Ependymal cells of the choroid plexus express tumour necrosis factor-α. Neuropathol. Appl. Neurobiol. 19: 324-328.
22. Beutler B. (1992) Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New York, Raven Press.
23. Tartaglia LA, Goeddel DV. (1992) Two TNF receptors. Immunol. Today 13: 151-153.
24. Rothe J, Gehr G, Loetscher H, Lesslauer W. (1992) Tumor necrosis factor receptors -structure and function. Immunol. Res. 11: 81-90.
25. Pfizenmaier K, Himmler A, Schutze S, Scheurich P, Kronke M. (1992) TNF receptors and TNF signal transduction. Beutler B (ed). In Tumor Necrosis Factors: The molecules and their emerging role in medicine. Raven Press, New York, pp. 439-472.
26. Vandenabeele P, Declercq W, Beyaert R, Fiers W (1995) Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5: 392-399.
27. Smith CA, Farrah T, Goodwin RG. (1994) The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 76: 959-962.
28. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Pallachino MA, Jr, Goeddell DV. (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U.S.A. 88: 9292-9295.
29. Tartaglia LA, Goeddell DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MA. (1993) Stimulation of human T-cell proliferation by specific activation of the 75-kD tumor necrosis factor receptor. J. Immunol. 151: 4637-4641.
30. Grell M, Scheurich P, Meager A, Pfizenmaier K. (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine and Cytokine Res. 12, Nov. 3: 143-148.
31. Tada M, Diserens A-C, Desbaillets I, et al. (1994) Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse transcription polymerase chain reaction. J. Neurosurg. 80: 1063-1073.
32. Shen Y, Li R, Shiosaki K. (1997) Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in a human neuronal cell line. J. Biol. Chem. 272: 3550-3553.
33. Zimmerman GA, Meistrell M III, Bloom O, Cockroft KM, Bianchi M, Risucci D, Broom J, Farmer P, Cerami A, Vlassara H, et al. (1995) Neurotoxicity of advanced glycation endproducts (AGEs) during focal stroke, and neuroprotective effects of aminoguanidine. Proc. Natl. Acad. Sci. U.S.A. 92: 3744-3748.
34. Cockroft KM, Meistrell M III, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ. (1996) Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27: 1393-1398.
35. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB. (1993) Distribution and caracterization of tumor necrosis factor-α-like immunoreactivity in the murinecentral nervous system. J. Comp. Neurol. 337: 543-567.
36. Kato HK, Kogure T, Araki T, Itoyoma Y. (1994) Astroglial and microglial responses in the gerbil hippocampus with induced ischemic intolerance. Brain Res. 664: 69-76.
37. Korematsu K, Goto S, Nagahiro S, Ushio Y. (1994) Microglial response to transient focal ischemia: An immunocytochemical study on the rat cerebral cortex using anti-phosphotyrosine antibody. J. Cereb. Blood Flow Metab. 14: 825-830.
38. Nishino H, Czurko A, Fukuda A, Hashitani T, Hida H, Karadi Z, Lenard L. (1994) Pathophysiological processes after transient ischemia of the middle cerebral artery in the rat. Brain Res. Bull. 35: 51-56.
39. Zimmer LA, Ennis M, Shipley MT. (1997) Soman-induced seizures rapidly activate astrocytes and microglia discrete brain regions. J. Comp. Neurol. 378: 482-492.
40. Garcia JE, Nonner D, Ross D, Barrett JN. (1992) Neurotoxic components in normal serum. Exp. Neurol. 118: 309-316.
41. Piani D, Spangler M, Schaffner A, Montana A. (1992) Macrophage-induced cytoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22: 2429-2436.
42. Hahn T, Toker L, Budilovsky S, Aderka D, Eahhar Z, Wallach D. (1985) Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein. Proc. Natl. Acad. Sci. U.S.A. 82: 3814-3818.
43. Nophar Y, Holtmann H, Ber R, Wallach D. (1988) Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokarions by fusion of resistant and sensitive cells. J. Immunol. 140: 3456-3460.
44. Wallach D. (1997) Cell death induction by TNF: A matter of self control. Trends Biochem. Sci. 22: 107-109.
45. Peck R, Brockhaus M, Frey JR. (1989) Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell Immunol. 122: 1-10.
46. Macchia D, Almeriogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. (1993) Membrane tumor necrosis factor is involved in the polyclonal B-cell activation induced by HIV infected human T-cells. Nature 363: 464-466.
47. Georgopulos S, Plows D, Kollias G. (1996) Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflammation 46: 86-87.
48. Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML. (1987) Production of cytotoxic factor from oligodentrocytes by stimulated astrocytes. J. Immunol. 139: 2593-2597.
49. Hofman FM, Hinton DR, Johnson K, Merill JE. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170: 607-612.
50. Arvin B, Neville LF, Barone FC, Feuerstein GK. (1995) Brain injury and inflammation. A putative role of TNF alpha. Ann. N.Y. Acad. Sci. 765: 62-99.
51. Wang XK, Yue T-L, Young PR, Barone FR, Feuerstein GZ. (1995) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15: 166-171.
52. Clark WM, Madden KP, Rothlein R, Zivin JA. (1991) Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75: 623-627.
53. Bowles WP, Zivin JA, Rothlein R. (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119: 215-219.
54. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, Jones M, Miyasaka M, Ward P. (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transcient middle cerebral artery occlusion in the rat. Neurology 44: 1747-1751.
55. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. (1990) Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U.S.A. 87: 6758-6761.
56. Chen H, Chopp M, Bodzin G. (1992) Neurotropenia reduces the volume of cerebral infarct after transient middle cerebral occlusion in the rat. Neurosci. Res. Commun. 11: 93-99.
57. Shiga Y, Onnodera H, Kogere K, Yamasaki Y, Yashima Y, Syozuhara H, Sendo F. (1991) Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125: 110-112.
58. Sippy BD, Hofman FM, Wallach D, Hinton DR. (1995) Increased expression of tumor necrosis factor-receptors in the brain of patients with AIDS. J. AIDS Hum. Retrovirol. 10: 511-521.
59. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 89: 4845-4849.
60. Keel M, Bonaccio M, Steckholder U, Ungethum U, Gallati H, Trentz O, Ertel W. (1995) Increased plasma level of Type 1 (p55) TNF-receptors following trauma. Swiss Surg. 5: 241-244.
61. Pinckard JK, Sheehan KC, Arthur CD, Schreiber. (1997) Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J. Immunol. 158: 3869-3873.
62. Banner D, D'Arcy A, Janes W, Gentz R, Schoenfeld H-J, Broger C, Loetscher H, Lesslauer W. (1993) Crystal structure of the soluble human 55 kd TNF receptor- human TNF-complex: Implications for TNF receptor activation. Cell 73: 431-445.
63. Chao CC, Hu S. (1994) Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16: 172-179.
64. Cheng B, Christakos S, Mattson MP. (1994) Tumor necrosis factors protect neurons against excitotoxic metabolic insults and promote maintenance of calcium homeostasis. Neuron 12: 139-153.
65. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. (1996) Inhibition of tumor necrosis factor alpha activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16: 378-384.